In Depth 24 Jan 2025 Why are there only 20 cell and gene therapies in Europe? There are 20 cell and gene therapies on Europe’s market versus 43 in the U.S. Find out more about this ecosystem. January 24, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 24 Jan 2025J.P. Morgan Annual Healthcare Conference 2025: trends and highlights you may have missed With Orca Bio’s CEO, Ivan Dimov,, we take a look at some of the highlights from the 43rd Annual J.P. Morgan Healthcare Conference January 24, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 23 Jan 2025 mRNA, RNAi, circRNA, ASOs: A comparative guide to RNA therapeutics In this review of RNA therapies, we paint an overview of what’s going on in a field that could address a number of diseases. January 23, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 20 Jan 2025 Is biotech M&A set to surge in 2025? There is big hope for biotech M&A in 2025, with a resounding sense that activity will rise again as several important factors come into play. January 20, 2025 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 17 Jan 2025 Are PD-1 and PD-L1 checkpoint inhibitors as good as we thought? Checkpoint inhibitors, especially those targeting PD-1 and PD-L1, are exploding in popularity. But how much of it is hype? January 17, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 17 Jan 2025Venture capital co-creation: The next big thing in biotech investment? This week, we talked with Jessica Owen, co-founder of Initiate Ventures, a venture firm with an interesting dual model. January 17, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
News and Trends 16 Jan 2025 Top biotech deals of December 2024 The month of December saw a variety of biotech deals take place to advance therapies across different stages in development. January 16, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 Jan 2025 Ten first-in-class drugs on track for FDA approval in 2025 As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval in 2025. January 16, 2025 - 13 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 15 Jan 2025 CRISPR: The gene editing tool changing the world (2025 update) CRISPR-Cas9 has changed the world with the promise of making gene editing much easier and faster than before. But what is its real potential? January 15, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Jan 2025 Singapore’s biotech scene: 7 companies leading the way in 2025 Discover seven of the top biotech companies in Singapore – a country that set out to become a global biotech hub just over 20 years ago. January 14, 2025 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 13 Jan 2025 2025 predictions: Which trends are set to shape the biotech industry this year? From AI to gene therapy, we reached out to industry experts to get their thoughts on the trends that will shape the biotech industry in 2025. January 13, 2025 - 18 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 10 Jan 2025 The in vivo revolution: How Interius, Umoja, and Vyriad are transforming CAR-T cell therapy A U.S. trial of an in vivo CAR gene therapy has expanded to Europe, marking the first-ever trial of its kind in the region. January 10, 2025 - 5 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email